Showing 381 - 400 of 1213 results
The Australian Nuclear Medicine Traceability Program (ANMTP) assists practices administering nuclear medicine-based radionuclides to achieve regulatory compliance by providing measurement traceability to the Australian Standard.
Neutron Capture Enhanced Particle Therapy developed at ANSTO.
Australian-first detector to accelerate cancer research unveiled.
Voucher scheme accelerating medical research
ANSTO has collaborated on a study assessing the impact of the commonly-used food additive titanium dioxide (TiO2) on gut microbiota and inflammation.
The Australian Synchrotron in Melbourne has a suite of X-ray and infrared beamlines with applications in health, medical, food, environment, nano-technology, energy, mining, advanced materials, agriculture and cultural heritage.
Favourable conceptual design review may lead to expanded role for Australia on ITER diagnostics.
When an energetic ion beam hits a sample it will interact with the atoms through a number of very complex interactions. By detecting and measuring the reaction products resulting from the various interactions and their intensities, you can obtain quantitative data on the sample's constituent elements and their spatial distribution.
The Think Science! event encourages students to engage with the Science Inquiry Skills process as outlined in the Australian National Curriculum.
ANSTO’s OPAL multi-purpose research reactor at Lucas Heights has officially returned to power and recommenced operations, following a months-long planned shutdown to carry out essential maintenance and upgrades.
Sample environments, Data analysis, SpICE and SICS
Environmental scientists at ANSTO have been undertaking research to gain a better understanding of the potential impact of contaminants on decommissioned offshore oil and gas infrastructure since 2017
This afternoon, the Chair of ANSTO, Dr Annabelle Bennett, wrote to all staff to let them know that CEO Dr Adi Paterson has decided to resign. She said the Board is deeply appreciative of the contributions Adi has made, including to the health, research and academic outputs of ANSTO during his tenure. Mr Shaun Jenkinson will continue as Acting CEO, while the Board undertakes a global search for a permanent CEO.
ANSTO expert in molecular imaging contributed to international workshop.
Sample environments, Data Analysis.
Doping with transition metals produced stability in bismuth oxide.